Literature DB >> 21149253

Risk factors for oligodendroglial tumors: a pooled international study.

Bridget J McCarthy1, Kristin M Rankin, Ken Aldape, Melissa L Bondy, Thomas Brännström, Helle Broholm, Maria Feychting, Dora Il'yasova, Peter D Inskip, Christoffer Johansen, Beatrice S Melin, Avima M Ruder, Mary Ann Butler, Michael E Scheurer, Joachim Schüz, Judith A Schwartzbaum, Margaret R Wrensch, Faith G Davis.   

Abstract

Oligodendroglial tumors are rare subtypes of brain tumors and are often combined with other glial tumors in epidemiological analyses. However, different demographic associations and clinical characteristics suggest potentially different risk factors. The purpose of this study was to investigate possible risk factors for oligodendroglial tumors (including oligodendroglioma, anaplastic oligodendroglioma, and mixed glioma). Data from 7 case-control studies (5 US and 2 Scandinavian) were pooled. Unconditional logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs), adjusted for age group, gender, and study site. Data on 617 cases and 1260 controls were available for analyses. Using data from all 7 studies, history of allergies and/or asthma was associated with a decreased risk of anaplastic oligodendroglioma (OR = 0.6; 95% CI: 0.4-0.9), and history of asthma only was associated with a decreased risk of oligodendroglioma (OR = 0.5; 95% CI: 0.3-0.9) and anaplastic oligodendroglioma (OR = 0.3; 95% CI: 0.1-0.9). A family history of brain tumors was associated with an increased risk of anaplastic oligodendroglioma (OR = 2.2; 95% CI: 1.1-4.5). Having had chicken pox was associated with a decreased risk of oligodendroglioma (OR = 0.6; 95% CI: 0.4-0.9) and anaplastic oligodendroglioma (OR = 0.5; 95% CI: 0.3-0.9) in the US studies. Although there is some overlap in risk factors between oligodendroglial tumors and gliomas as a group, it is likely that additional factors specific to oligodendroglial tumors have yet to be identified. Large, multi-institution international studies will be necessary to better characterize these etiological risk factors.

Entities:  

Mesh:

Year:  2010        PMID: 21149253      PMCID: PMC3064625          DOI: 10.1093/neuonc/noq173

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  39 in total

1.  Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.

Authors:  G S Bauman; Y Ino; K Ueki; M C Zlatescu; B J Fisher; D R Macdonald; L Stitt; D N Louis; J G Cairncross
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-10-01       Impact factor: 7.038

2.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

Authors:  J S Smith; A Perry; T J Borell; H K Lee; J O'Fallon; S M Hosek; D Kimmel; A Yates; P C Burger; B W Scheithauer; R B Jenkins
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

Review 3.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

4.  History of allergies among adults with glioma and controls.

Authors:  Joseph L Wiemels; John K Wiencke; Jennette D Sison; Rei Miike; Alex McMillan; Margaret Wrensch
Journal:  Int J Cancer       Date:  2002-04-01       Impact factor: 7.396

5.  The Upper Midwest Health Study: a case-control study of primary intracranial gliomas in farm and rural residents.

Authors:  A M Ruder; M A Waters; T Carreón; M A Butler; K E Davis-King; G M Calvert; P A Schulte; E M Ward; L B Connally; J Lu; D Wall; Z Zivkovich; E F Heineman; J S Mandel; R F Morton; D J Reding; K D Rosenman
Journal:  J Agric Saf Health       Date:  2006-11

6.  Genome-wide association study identifies five susceptibility loci for glioma.

Authors:  Sanjay Shete; Fay J Hosking; Lindsay B Robertson; Sara E Dobbins; Marc Sanson; Beatrice Malmer; Matthias Simon; Yannick Marie; Blandine Boisselier; Jean-Yves Delattre; Khe Hoang-Xuan; Soufiane El Hallani; Ahmed Idbaih; Diana Zelenika; Ulrika Andersson; Roger Henriksson; A Tommy Bergenheim; Maria Feychting; Stefan Lönn; Anders Ahlbom; Johannes Schramm; Michael Linnebank; Kari Hemminki; Rajiv Kumar; Sarah J Hepworth; Amy Price; Georgina Armstrong; Yanhong Liu; Xiangjun Gu; Robert Yu; Ching Lau; Minouk Schoemaker; Kenneth Muir; Anthony Swerdlow; Mark Lathrop; Melissa Bondy; Richard S Houlston
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

7.  Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995.

Authors:  Shuji Yonehara; Alina V Brenner; Masao Kishikawa; Peter D Inskip; Dale L Preston; Elaine Ron; Kiyohiko Mabuchi; Shoji Tokuoka
Journal:  Cancer       Date:  2004-10-01       Impact factor: 6.860

8.  Comparing the reliability of responses to telephone-administered versus self-administered Web-based surveys in a case-control study of adult malignant brain cancer.

Authors:  Kristin M Rankin; Garth H Rauscher; Bridget McCarthy; Serap Erdal; Pat Lada; Dora Il'yasova; Faith Davis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

9.  Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls.

Authors:  Dora Il'yasova; Bridget McCarthy; Jennifer Marcello; Joellen M Schildkraut; Patricia G Moorman; Bhuma Krishnamachari; Francis Ali-Osman; Darell D Bigner; Faith Davis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

10.  Incidence trends of adult primary intracerebral tumors in four Nordic countries.

Authors:  Stefan Lönn; Lars Klaeboe; Per Hall; Tiit Mathiesen; Anssi Auvinen; Helle C Christensen; Christoffer Johansen; Tiina Salminen; Tore Tynes; Maria Feychting
Journal:  Int J Cancer       Date:  2004-01-20       Impact factor: 7.396

View more
  10 in total

1.  Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France.

Authors:  Amélie Darlix; Sonia Zouaoui; Jean-Marc Virion; Valérie Rigau; Hélène Mathieu-Daudé; Marie Blonski; German Reyes-Botero; Faiza Bessaoud; Brigitte Trétarre; Fabienne Bauchet; Laurent Capelle; Michel Fabbro; Christine Kerr; Dominique Figarella-Branger; Hugues Duffau; Luc Taillandier; Luc Bauchet
Journal:  J Neurooncol       Date:  2014-08-24       Impact factor: 4.130

2.  Integration of epidemiology, immunobiology, and translational research for brain tumors.

Authors:  Hideho Okada; Michael E Scheurer; Saumendra N Sarkar; Melissa L Bondy
Journal:  Ann N Y Acad Sci       Date:  2013-05       Impact factor: 5.691

Review 3.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

4.  A pooled multisite analysis of the effects of atopic medical conditions in glioma risk in different ethnic groups.

Authors:  Bhuma Krishnamachari; Dora Il'yasova; Michael E Scheurer; Melissa Bondy; Renke Zhou; Margaret Wrensch; Faith Davis
Journal:  Ann Epidemiol       Date:  2015-01-03       Impact factor: 3.797

5.  Association of the presence of allergic disease with subsequent risk of liver cancer in a nationwide retrospective cohort among Koreans.

Authors:  Ji Ah Kim; Sun Jae Park; Seulggie Choi; Jooyoung Chang; Seogsong Jeong; Joseph C Ahn; Gyeongsil Lee; Joung Sik Son; Sang Min Park
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

6.  Familial gliomas: cases in two pairs of brothers.

Authors:  Joseph A Osorio; Shawn L Hervey-Jumper; Kyle M Walsh; Jennifer L Clarke; Nicholas A Butowski; Michael D Prados; Mitchel S Berger
Journal:  J Neurooncol       Date:  2014-09-11       Impact factor: 4.130

7.  Family history of cancer in benign brain tumor subtypes versus gliomas.

Authors:  Quinn T Ostrom; Christopher McCulloh; Yanwen Chen; Karen Devine; Yingli Wolinsky; Perica Davitkov; Sarah Robbins; Rajesh Cherukuri; Ashokkumar Patel; Rajnish Gupta; Mark Cohen; Jaime Vengoechea Barrios; Cathy Brewer; Cathy Schilero; Kathy Smolenski; Mary McGraw; Barbara Denk; Theresa Naska; Frances Laube; Ruth Steele; Dale Greene; Alison Kastl; Susan Bell; Dina Aziz; E A Chiocca; Christopher McPherson; Ronald Warnick; Gene H Barnett; Andrew E Sloan; Jill S Barnholtz-Sloan
Journal:  Front Oncol       Date:  2012-02-28       Impact factor: 6.244

8.  Alcohol consumption and risk of glioma: a meta-analysis of 19 observational studies.

Authors:  Zhen-Yu Qi; Chuan Shao; Chao Yang; Zhong Wang; Guo-Zhen Hui
Journal:  Nutrients       Date:  2014-01-27       Impact factor: 5.717

Review 9.  Disparities in Brain Cancer in the United States: A Literature Review of Gliomas.

Authors:  Dharam Persaud-Sharma; Joseph Burns; Jeran Trangle; Sabyasachi Moulik
Journal:  Med Sci (Basel)       Date:  2017-07-25

10.  Diet and risk of glioma: combined analysis of 3 large prospective studies in the UK and USA.

Authors:  Ai Seon Kuan; Jane Green; Cari M Kitahara; Amy Berrington De González; Tim Key; Gillian K Reeves; Sarah Floud; Angela Balkwill; Kathryn Bradbury; Linda M Liao; Neal D Freedman; Valerie Beral; Siân Sweetland
Journal:  Neuro Oncol       Date:  2019-07-11       Impact factor: 12.300

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.